IONS Ionis Pharmaceuticals | $31.71
+3.3% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $65.00 -> $64.00 | Medium | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/1/2025 |
PEG Public Service Enterprise Group | $78.61
-1.7% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $98.00 -> $94.00 | High | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 5/1/2025 |
REGN Regeneron Pharmaceuticals | $590.00
-1.5% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $940.00 -> $810.00 | Low | View details for Guggenheim rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/1/2025 |
FSLR First Solar | $126.57
+0.6% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $253.00 -> $202.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 5/1/2025 |
MSFT Microsoft | $425.40
+7.6% | 5/1/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 5/1/2025 |
CFLT Confluent | $19.44
-18.4% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $38.00 -> $31.00 | High | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 5/1/2025 |
PPL PPL | $36.08
-1.2% | 5/1/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $38.00 -> $40.00 | Low | View details for Guggenheim rating of PPL (NYSE:PPL) on 5/1/2025 |
META Meta Platforms | $572.21
+4.2% | 5/1/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $675.00 -> $725.00 | High | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 5/1/2025 |
LLY Eli Lilly and Company | $794.67
-11.6% | 5/1/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | High | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 5/1/2025 |
EWTX Edgewise Therapeutics | $16.68
+1.7% | 4/30/2025 | Initiated by | Guggenheim | Analyst D. Chattopadhyay | Buy | $41.00 | High | View details for Guggenheim rating of Edgewise Therapeutics (NASDAQ:EWTX) on 4/30/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
CNC Centene | $59.39
-0.8% | 4/29/2025 | Reiterated by | Guggenheim | Analyst J. Cassorla | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Centene (NYSE:CNC) on 4/29/2025 |
URGN UroGen Pharma | $11.41
-2.0% | 4/29/2025 | Reiterated by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | | High | View details for Guggenheim rating of UroGen Pharma (NASDAQ:URGN) on 4/29/2025 |
SBUX Starbucks | $82.01
+2.4% | 4/29/2025 | Target Lowered by | Guggenheim | Analyst Gregory Francfort | Neutral -> Neutral | $95.00 -> $83.00 | Medium | View details for Guggenheim rating of Starbucks (NASDAQ:SBUX) on 4/29/2025 |
ABBV AbbVie | $193.40
-0.9% | 4/29/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $214.00 -> $216.00 | Low | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 4/29/2025 |
CMG Chipotle Mexican Grill | $50.31
-0.4% | 4/25/2025 | Target Set by | Guggenheim | - | | $47.00 | Low | View details for Guggenheim rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2025 |
SWTX SpringWorks Therapeutics | $46.21
-0.2% | 4/28/2025 | Downgraded by | Guggenheim | Analyst Michael Schmidt | Buy -> Neutral | $77.00 -> $47.00 | Low | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 4/28/2025 |
PCG PG&E | $16.67
+0.9% | 4/25/2025 | Target Raised by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $16.00 -> $17.00 | Low | View details for Guggenheim rating of PG&E (NYSE:PCG) on 4/25/2025 |
TSCO Tractor Supply | $50.35
-0.5% | 4/25/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $55.00 | Low | View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 4/25/2025 |
EPAM EPAM Systems | $158.46
+1.0% | 4/25/2025 | Target Lowered by | Guggenheim | Analyst Jonathan Lee | Buy -> Buy | $285.00 -> $210.00 | Low | View details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 4/25/2025 |
AEE Ameren | $98.04
-1.2% | 4/22/2025 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | Low | View details for Guggenheim rating of Ameren (NYSE:AEE) on 4/22/2025 |
EXC Exelon | $46.60
-0.6% | 4/22/2025 | Target Set by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $47.00 | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 4/22/2025 |
TSLA Tesla | $280.52
-0.6% | 4/24/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | $170.00 -> $170.00 | Medium | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 4/24/2025 |
NOW ServiceNow | $958.88
+0.4% | 4/24/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Sell -> Sell | $716.00 -> $724.00 | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 4/24/2025 |
GEV GE Vernova | $382.27
+3.1% | 4/24/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $380.00 -> $380.00 | Low | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 4/24/2025 |
MSFT Microsoft | $425.40
+7.6% | 4/23/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 4/23/2025 |
ELV Elevance Health | $408.52
-2.9% | 4/23/2025 | Reiterated by | Guggenheim | Analyst J. Cassorla | Buy -> Buy | $518.00 -> $518.00 | Low | View details for Guggenheim rating of Elevance Health (NYSE:ELV) on 4/23/2025 |
CTSH Cognizant Technology Solutions | $75.23
+2.3% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Jonathan Lee | Neutral -> Neutral | | Low | View details for Guggenheim rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 4/23/2025 |
DHR Danaher | $196.90
-1.2% | 4/23/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $250.00 -> $250.00 | Medium | View details for Guggenheim rating of Danaher (NYSE:DHR) on 4/23/2025 |
SPHR Sphere Entertainment | $27.02
-0.8% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $69.00 -> $69.00 | Low | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 4/23/2025 |
TKO TKO Group | $163.41
+0.3% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $175.00 -> $175.00 | Low | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 4/23/2025 |
CVLT Commvault Systems | $166.02
-0.7% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Commvault Systems (NASDAQ:CVLT) on 4/23/2025 |
CFLT Confluent | $19.44
-18.4% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $38.00 -> $38.00 | Low | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 4/23/2025 |
SEDG SolarEdge Technologies | $12.54
+2.5% | 4/23/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $5.00 | High | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 4/23/2025 |
ENPH Enphase Energy | $44.55
-0.1% | 4/23/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $33.00 | High | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 4/23/2025 |
NVO Novo Nordisk A/S | $65.67
-1.2% | 4/17/2025 | Downgraded by | Guggenheim | Analyst S. Fernandez | Strong-Buy -> Hold | | Low | View details for Guggenheim rating of Novo Nordisk A/S (NYSE:NVO) on 4/17/2025 |
CMG Chipotle Mexican Grill | $50.31
-0.4% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Gregory Francfort | Neutral -> Neutral | $56.00 -> $48.00 | Low | View details for Guggenheim rating of Chipotle Mexican Grill (NYSE:CMG) on 4/22/2025 |
DPZ Domino's Pizza | $481.39
-1.8% | 4/22/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Neutral -> Neutral | $450.00 -> $460.00 | High | View details for Guggenheim rating of Domino’s Pizza (NASDAQ:DPZ) on 4/22/2025 |
CMPX Compass Therapeutics | $1.82
-2.2% | 4/22/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 4/22/2025 |
VC Visteon | $79.39
+0.3% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $108.00 -> $91.00 | Low | View details for Guggenheim rating of Visteon (NASDAQ:VC) on 4/22/2025 |
LAD Lithia Motors | $293.82
+0.4% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $417.00 -> $356.00 | Medium | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 4/22/2025 |
Massive new energy source found in Utah (Ad) NEW THIS WEEK: Huge Energy Discovery In Utah
The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested. Find out what billionaires already know about this new energy source |
GPI Group 1 Automotive | $405.46
+0.5% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $502.00 -> $426.00 | High | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 4/22/2025 |
GNTX Gentex | $21.66
-0.6% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $30.00 -> $24.00 | Low | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 4/22/2025 |
BWA BorgWarner | $28.60
+0.8% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $38.00 -> $33.00 | Low | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 4/22/2025 |
APTV Aptiv | $57.00
-0.1% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $75.00 -> $64.00 | Low | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 4/22/2025 |
AN AutoNation | $174.97
+0.5% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $212.00 -> $183.00 | Low | View details for Guggenheim rating of AutoNation (NYSE:AN) on 4/22/2025 |
CRM Salesforce | $269.17
+0.2% | 4/21/2025 | Upgraded by | Guggenheim | Analyst J. Difucci | Sell -> Neutral | | Medium | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 4/21/2025 |
UNCY Unicycive Therapeutics | $0.65
-0.2% | 4/21/2025 | Initiated by | Guggenheim | Analyst Vamil Divan | Buy | $6.00 | High | View details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 4/21/2025 |
NFLX Netflix | $1,133.47
+0.2% | 4/18/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $1,100.00 -> $1,150.00 | N/A | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/18/2025 |
MRK Merck & Co., Inc. | $83.30
-2.2% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $115.00 -> $115.00 | Low | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 4/17/2025 |
GEV GE Vernova | $382.27
+3.1% | 4/17/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $380.00 -> $380.00 | Low | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 4/17/2025 |
ITRI Itron | $108.05
-2.9% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $133.00 -> $133.00 | Low | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 4/17/2025 |
ABBV AbbVie | $193.40
-0.9% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $214.00 -> $214.00 | Low | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 4/17/2025 |
NOW ServiceNow | $958.88
+0.4% | 4/16/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Sell -> Sell | $716.00 -> $716.00 | High | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 4/16/2025 |
CYRX Cryoport | $5.46
-2.2% | 4/16/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for Guggenheim rating of Cryoport (NASDAQ:CYRX) on 4/16/2025 |
ONC Beigene | $255.64
-1.6% | 4/16/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Medium | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 4/16/2025 |
VERV Verve Therapeutics | $5.50
-3.0% | 4/15/2025 | Target Raised by | Guggenheim | Analyst Etzer Darout | Buy -> Buy | $18.00 -> $24.00 | High | View details for Guggenheim rating of Verve Therapeutics (NASDAQ:VERV) on 4/15/2025 |
FLNC Fluence Energy | $4.28
+4.6% | 4/15/2025 | Target Lowered by | Guggenheim | Analyst J. Osha | Sell -> Sell | $6.00 -> $2.00 | High | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 4/15/2025 |
LLY Eli Lilly and Company | $794.67
-11.6% | 4/14/2025 | Target Lowered by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $973.00 -> $928.00 | Low | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 4/14/2025 |
PLNT Planet Fitness | $94.85
+0.3% | 4/14/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $105.00 -> $110.00 | Low | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 4/14/2025 |
USFD US Foods | $66.31
+1.0% | 4/14/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $80.00 -> $80.00 | Low | View details for Guggenheim rating of US Foods (NYSE:USFD) on 4/14/2025 |
TVTX Travere Therapeutics | $20.76
-0.2% | 4/14/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $47.00 -> $47.00 | Low | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 4/14/2025 |
EXAS Exact Sciences | $47.16
+3.3% | 4/11/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $60.00 -> $60.00 | High | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 4/11/2025 |
TGNA TEGNA | $16.07
-1.0% | 4/11/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $22.00 -> $20.00 | Low | View details for Guggenheim rating of TEGNA (NYSE:TGNA) on 4/11/2025 |
ANIP ANI Pharmaceuticals | $70.69
-0.2% | 4/11/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $86.00 -> $86.00 | High | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 4/11/2025 |
ONC Beigene | $255.64
-1.6% | 4/10/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $348.00 -> $348.00 | High | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 4/10/2025 |
PRIM Primoris Services | $64.14
+6.9% | 4/10/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $110.00 -> $110.00 | Low | View details for Guggenheim rating of Primoris Services (NASDAQ:PRIM) on 4/10/2025 |
MBX MBX Biosciences | $11.28
+7.5% | 4/10/2025 | Reiterated by | Guggenheim | Analyst S. Fernandez | Buy -> Buy | $44.00 -> $44.00 | Medium | View details for Guggenheim rating of MBX Biosciences (NYSE:MBX) on 4/10/2025 |
DKNG DraftKings | $33.26
-0.1% | 4/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $62.00 -> $61.00 | Low | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 4/10/2025 |
NEOG Neogen | $5.15
+2.0% | 4/10/2025 | Target Lowered by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $15.00 -> $13.00 | High | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 4/10/2025 |
ACHC Acadia Healthcare | $22.78
-2.6% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $36.00 | High | View details for Guggenheim rating of Acadia Healthcare (NASDAQ:ACHC) on 4/9/2025 |
CI The Cigna Group | $335.21
-1.4% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $384.00 | High | View details for Guggenheim rating of The Cigna Group (NYSE:CI) on 4/9/2025 |
HUM Humana | $256.11
-2.3% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $326.00 | High | View details for Guggenheim rating of Humana (NYSE:HUM) on 4/9/2025 |
HCA HCA Healthcare | $342.93
-0.6% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | High | View details for Guggenheim rating of HCA Healthcare (NYSE:HCA) on 4/9/2025 |
CYH Community Health Systems | $2.77
+1.3% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | High | View details for Guggenheim rating of Community Health Systems (NYSE:CYH) on 4/9/2025 |
UHS Universal Health Services | $174.71
-1.3% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $208.00 | High | View details for Guggenheim rating of Universal Health Services (NYSE:UHS) on 4/9/2025 |
THC Tenet Healthcare | $145.41
+1.7% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $165.00 | High | View details for Guggenheim rating of Tenet Healthcare (NYSE:THC) on 4/9/2025 |
MOH Molina Healthcare | $313.50
-4.1% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | Medium | View details for Guggenheim rating of Molina Healthcare (NYSE:MOH) on 4/9/2025 |
CNC Centene | $59.39
-0.8% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | Medium | View details for Guggenheim rating of Centene (NYSE:CNC) on 4/9/2025 |
ELV Elevance Health | $408.52
-2.9% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $518.00 | High | View details for Guggenheim rating of Elevance Health (NYSE:ELV) on 4/9/2025 |
VCYT Veracyte | $29.71
-2.6% | 4/9/2025 | Target Lowered by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $45.00 -> $37.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 4/9/2025 |
ARDT Ardent Health Partners | $12.57
-1.2% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $16.00 | High | View details for Guggenheim rating of Ardent Health Partners (NYSE:ARDT) on 4/9/2025 |
MYGN Myriad Genetics | $7.13
-3.8% | 4/9/2025 | Downgraded by | Guggenheim | Analyst Subbu Nambi | Buy -> Neutral | | High | View details for Guggenheim rating of Myriad Genetics (NASDAQ:MYGN) on 4/9/2025 |
META Meta Platforms | $572.21
+4.2% | 4/8/2025 | Target Lowered by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $750.00 -> $675.00 | Medium | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 4/8/2025 |
YUM Yum! Brands | $148.65
-1.2% | 4/8/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $155.00 -> $165.00 | High | View details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 4/8/2025 |
FE FirstEnergy | $42.77
-0.3% | 4/7/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $45.00 -> $47.00 | Low | View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 4/7/2025 |
FSLR First Solar | $126.57
+0.6% | 4/7/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $304.00 -> $253.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 4/7/2025 |
IVA Inventiva | $3.50
-5.4% | 4/4/2025 | Target Lowered by | Guggenheim | Analyst Etzer Darout | Buy -> Buy | $12.00 -> $9.00 | High | View details for Guggenheim rating of Inventiva (NASDAQ:IVA) on 4/4/2025 |
QSR Restaurant Brands International | $65.29
+1.4% | 4/4/2025 | Target Raised by | Guggenheim | Analyst G. Francfort | Buy -> Buy | $71.00 -> $77.00 | High | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 4/4/2025 |
NBTX Nanobiotix | $3.31
-2.4% | 4/4/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $12.00 -> $8.00 | Low | View details for Guggenheim rating of Nanobiotix (NASDAQ:NBTX) on 4/4/2025 |
IONS Ionis Pharmaceuticals | $31.71
+3.3% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | High | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/3/2025 |
Trump Makes Major Crypto Announcement (Ad) Trump's Pro-Crypto Agenda Finally Sparks Market Recovery
With Bitcoin surging past $90,000 and altcoins heating up, I'm seeing all the signs of a major market shift
For a limited time, I'm revealing the name and complete analysis behind my top Trump-era crypto pick.  Click here to check it out now |
ARQT Arcutis Biotherapeutics | $14.65
-1.7% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Medium | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 4/3/2025 |
RH RH | $185.24
+0.7% | 4/3/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $500.00 -> $300.00 | High | View details for Guggenheim rating of RH (NYSE:RH) on 4/3/2025 |
KR Kroger | $72.20
0.0% | 4/3/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $71.00 -> $73.00 | High | View details for Guggenheim rating of Kroger (NYSE:KR) on 4/3/2025 |
NFLX Netflix | $1,133.47
+0.2% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $1,100.00 -> $1,100.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/3/2025 |
SRAD Sportradar Group | $23.47
+1.6% | 4/3/2025 | Reiterated by | Guggenheim | Analyst C. Baker | Buy -> Buy | $27.00 -> $27.00 | Low | View details for Guggenheim rating of Sportradar Group (NASDAQ:SRAD) on 4/3/2025 |
ORCL Oracle | $145.50
+3.4% | 4/3/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $220.00 -> $220.00 | Low | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 4/3/2025 |
TWST Twist Bioscience | $37.71
-1.6% | 3/28/2025 | Target Set by | Guggenheim | - | | $50.00 | High | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 3/28/2025 |
CMPX Compass Therapeutics | $1.82
-2.2% | 4/2/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $12.00 -> $12.00 | High | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 4/2/2025 |
MAZE Maze Therapeutics | $10.59
+14.5% | 4/2/2025 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $19.00 -> $19.00 | Medium | View details for Guggenheim rating of Maze Therapeutics (NASDAQ:MAZE) on 4/2/2025 |
SNAP Snap | $7.83
-1.7% | 4/2/2025 | Reiterated by | Guggenheim | Analyst M. Morris | Neutral -> Neutral | | Low | View details for Guggenheim rating of Snap (NYSE:SNAP) on 4/2/2025 |
PHAT Phathom Pharmaceuticals | $3.36
-21.7% | 4/2/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 4/2/2025 |
JNJ Johnson & Johnson | $154.42
-1.2% | 4/2/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | | Low | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 4/2/2025 |
PINS Pinterest | $25.50
+0.7% | 4/1/2025 | Reiterated by | Guggenheim | Analyst M. Morris | Buy -> Buy | | Low | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 4/1/2025 |
SR Spire | $76.50
-0.1% | 4/1/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $67.00 -> $72.00 | Medium | View details for Guggenheim rating of Spire (NYSE:SR) on 4/1/2025 |
PRGS Progress Software | $60.13
+0.3% | 4/1/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $83.00 -> $83.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 4/1/2025 |
PMN ProMIS Neurosciences | $0.65
+4.9% | 4/1/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $6.00 -> $6.00 | High | View details for Guggenheim rating of ProMIS Neurosciences (NASDAQ:PMN) on 4/1/2025 |
CABA Cabaletta Bio | $1.25
-5.3% | 4/1/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $23.00 -> $23.00 | High | View details for Guggenheim rating of Cabaletta Bio (NASDAQ:CABA) on 4/1/2025 |
ADCT ADC Therapeutics | $1.45
+1.0% | 3/31/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $10.00 -> $7.00 | High | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 3/31/2025 |
BROS Dutch Bros | $59.83
+0.2% | 3/31/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $54.00 -> $72.00 | Medium | View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 3/31/2025 |
DLTR Dollar Tree | $81.27
-0.6% | 3/28/2025 | Target Lowered by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $100.00 -> $95.00 | Medium | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 3/28/2025 |
MRUS Merus | $45.45
-0.1% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $109.00 -> $109.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 3/28/2025 |
IPSC Century Therapeutics | $0.56
+2.5% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | | High | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 3/28/2025 |
SLNO Soleno Therapeutics | $75.02
+0.2% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $70.00 -> $81.00 | High | View details for Guggenheim rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/28/2025 |
CSTL Castle Biosciences | $19.31
-3.7% | 3/28/2025 | Target Set by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $30.00 | High | View details for Guggenheim rating of Castle Biosciences (NASDAQ:CSTL) on 3/28/2025 |
EXAS Exact Sciences | $47.16
+3.3% | 3/28/2025 | Target Set by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $60.00 | High | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 3/28/2025 |
CNTA Centessa Pharmaceuticals | $13.50
-1.5% | 3/26/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $28.00 -> $28.00 | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 3/26/2025 |
RH RH | $185.24
+0.7% | 3/26/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $550.00 -> $500.00 | Medium | View details for Guggenheim rating of RH (NYSE:RH) on 3/26/2025 |
IFRX InflaRx | $1.85
+8.8% | 3/26/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $7.00 -> $10.00 | High | View details for Guggenheim rating of InflaRx (NASDAQ:IFRX) on 3/26/2025 |
ADAP Adaptimmune Therapeutics | $0.28
-0.6% | 3/26/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $3.00 -> $1.75 | High | View details for Guggenheim rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 3/26/2025 |
ZURA Zura Bio | $1.47
-4.5% | 3/26/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for Guggenheim rating of Zura Bio (NASDAQ:ZURA) on 3/26/2025 |
MTZ MasTec | $134.00
+5.2% | 3/25/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $195.00 -> $195.00 | Low | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 3/25/2025 |
FOXA FOX | $49.22
-1.1% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 3/25/2025 |
LRMR Larimar Therapeutics | $2.86
+7.9% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $26.00 -> $26.00 | Medium | View details for Guggenheim rating of Larimar Therapeutics (NASDAQ:LRMR) on 3/25/2025 |
VERV Verve Therapeutics | $5.50
-3.0% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Verve Therapeutics (NASDAQ:VERV) on 3/25/2025 |
ASMB Assembly Biosciences | $11.44
+0.4% | 3/25/2025 | Initiated by | Guggenheim | Analyst Vamil Divan | Buy | $31.00 | Low | View details for Guggenheim rating of Assembly Biosciences (NASDAQ:ASMB) on 3/25/2025 |
DRI Darden Restaurants | $199.76
-0.4% | 3/24/2025 | Target Raised by | Guggenheim | Analyst Greg Francfort | Buy -> Buy | $205.00 -> $220.00 | High | View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 3/24/2025 |
VSTM Verastem | $7.43
-0.8% | 3/24/2025 | Target Raised by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $13.00 -> $14.00 | Medium | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 3/24/2025 |
VALN Valneva | $6.45
+1.7% | 3/24/2025 | Target Lowered by | Guggenheim | Analyst Dana Flanders | Buy -> Buy | $17.00 -> $15.00 | High | View details for Guggenheim rating of Valneva (NASDAQ:VALN) on 3/24/2025 |
PINS Pinterest | $25.50
+0.7% | 3/24/2025 | Upgraded by | Guggenheim | Analyst Michael Morris | Neutral -> Buy | $39.00 -> $40.00 | Low | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 3/24/2025 |
ACN Accenture | $300.79
+0.5% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst Jonathan Lee | Buy -> Buy | $400.00 -> $395.00 | High | View details for Guggenheim rating of Accenture (NYSE:ACN) on 3/21/2025 |
DTE DTE Energy | $135.76
-0.9% | 3/21/2025 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $139.00 -> $147.00 | Medium | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 3/21/2025 |
IPSC Century Therapeutics | $0.56
+2.5% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | $12.00 -> $5.00 | Medium | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 3/21/2025 |
FIVE Five Below | $75.36
-0.7% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $140.00 -> $125.00 | Medium | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 3/21/2025 |
ACET Adicet Bio | $0.63
-4.8% | 3/21/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Guggenheim rating of Adicet Bio (NASDAQ:ACET) on 3/21/2025 |
NEE NextEra Energy | $66.04
-1.3% | 3/20/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $89.00 -> $89.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 3/20/2025 |
IMVT Immunovant | $15.90
-1.5% | 3/20/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 3/20/2025 |
RDDT Reddit | $118.40
+1.6% | 3/20/2025 | Target Lowered by | Guggenheim | Analyst M. Morris | Buy -> Buy | $210.00 -> $170.00 | Medium | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 3/20/2025 |
IMNM Immunome | $8.86
+0.8% | 3/20/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $35.00 -> $25.00 | Medium | View details for Guggenheim rating of Immunome (NASDAQ:IMNM) on 3/20/2025 |
ABSI Absci | $3.03
-1.3% | 3/20/2025 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 3/20/2025 |
EOSE Eos Energy Enterprises | $5.14
-1.5% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Guggenheim rating of Eos Energy Enterprises (NASDAQ:EOSE) on 3/18/2025 |
Massive new energy source found in Utah (Ad) NEW THIS WEEK: Huge Energy Discovery In Utah
The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested. Find out what billionaires already know about this new energy source |
MRUS Merus | $45.45
-0.1% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $109.00 -> $109.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 3/18/2025 |
PFE Pfizer | $23.91
-2.1% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 3/18/2025 |
ZBIO Zenas Biopharma | $11.56
-0.2% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Y. Suneja | Buy -> Buy | $45.00 -> $45.00 | Medium | View details for Guggenheim rating of Zenas Biopharma (NASDAQ:ZBIO) on 3/12/2025 |
RBRK Rubrik | $71.18
+0.9% | 3/18/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Buy -> Buy | $76.00 -> $80.00 | Low | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 3/18/2025 |
GENI Genius Sports | $10.79
0.0% | 3/18/2025 | Initiated by | Guggenheim | Analyst Curry Baker | Buy | $12.00 | High | View details for Guggenheim rating of Genius Sports (NYSE:GENI) on 3/18/2025 |
INCY Incyte | $62.03
-1.0% | 3/18/2025 | Downgraded by | Guggenheim | Analyst Michael Schmidt | Buy -> Neutral | $92.00 -> $92.00 | High | View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 3/18/2025 |
GNRC Generac | $112.74
-1.4% | 3/17/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | Low | View details for Guggenheim rating of Generac (NYSE:GNRC) on 3/17/2025 |
ZVRA Zevra Therapeutics | $7.64
+4.2% | 3/13/2025 | Target Raised by | Guggenheim | Analyst E. Hickman | Buy -> Buy | $20.00 -> $22.00 | Medium | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/13/2025 |
ARVN Arvinas | $7.23
-24.8% | 3/13/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $57.00 -> $32.00 | Low | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 3/13/2025 |
GHRS GH Research | $10.77
+12.9% | 3/13/2025 | Initiated by | Guggenheim | Analyst Eddie Hickman | Buy | $32.00 | Medium | View details for Guggenheim rating of GH Research (NASDAQ:GHRS) on 3/13/2025 |
CYBN Cybin | $6.62
-1.5% | 3/13/2025 | Initiated by | Guggenheim | Analyst Eddie Hickman | Buy | $35.00 | High | View details for Guggenheim rating of Cybin (NYSE:CYBN) on 3/13/2025 |
LEGN Legend Biotech | $33.96
-2.8% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Legend Biotech (NASDAQ:LEGN) on 3/12/2025 |
DKS DICK'S Sporting Goods | $187.35
-0.2% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Neutral -> Neutral | | Low | View details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 3/12/2025 |
DNTH Dianthus Therapeutics | $21.70
-0.7% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $84.00 -> $84.00 | High | View details for Guggenheim rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/12/2025 |
PCVX Vaxcyte | $35.24
-1.7% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $160.00 -> $160.00 | Low | View details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 3/12/2025 |
PFE Pfizer | $23.91
-2.1% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 3/12/2025 |
TSLA Tesla | $280.52
-0.6% | 3/12/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | $175.00 -> $170.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 3/12/2025 |
GNTX Gentex | $21.66
-0.6% | 3/5/2025 | Target Set by | Guggenheim | - | | $30.00 | Low | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 3/5/2025 |
ANAB AnaptysBio | $21.70
-2.3% | 3/3/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | High | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 3/3/2025 |
GTN Gray Television | $3.35
-0.1% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $8.00 -> $7.00 | Medium | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 3/10/2025 |
ORLY O'Reilly Automotive | $1,407.68
-0.5% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $1,475.00 -> $1,475.00 | Low | View details for Guggenheim rating of O’Reilly Automotive (NASDAQ:ORLY) on 3/10/2025 |
W Wayfair | $31.27
+3.7% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 3/10/2025 |
JNJ Johnson & Johnson | $154.42
-1.2% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 3/10/2025 |
IMVT Immunovant | $15.90
-1.5% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | Low | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 3/10/2025 |
NAUT Nautilus Biotechnology | $0.68
-0.5% | 2/28/2025 | Target Set by | Guggenheim | - | | $2.50 | High | View details for Guggenheim rating of Nautilus Biotechnology (NASDAQ:NAUT) on 2/28/2025 |
ONC Beigene | $255.64
-1.6% | 2/28/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 2/28/2025 |
FWONA Formula One Group | $81.97
+1.8% | 3/3/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Formula One Group (NASDAQ:FWONA) on 3/3/2025 |
ARGX argenx | $639.90
-0.8% | 3/10/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $775.00 -> $1,100.00 | Medium | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 3/10/2025 |
IHRT iHeartMedia | $1.06
+2.9% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $5.00 -> $4.50 | Medium | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 3/10/2025 |
SBGI Sinclair | $14.60
+1.4% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $19.00 -> $17.00 | High | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 3/10/2025 |
VG Venture Global | $8.72
+3.9% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $27.00 -> $20.00 | High | View details for Guggenheim rating of Venture Global (NYSE:VG) on 3/10/2025 |
BWA BorgWarner | $28.60
+0.8% | 3/5/2025 | Target Set by | Guggenheim | - | | $38.00 | N/A | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 3/5/2025 |
PHAT Phathom Pharmaceuticals | $3.36
-21.7% | 3/7/2025 | Target Set by | Guggenheim | - | | $18.00 | N/A | View details for Guggenheim rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 3/7/2025 |
AVBP ArriVent BioPharma | $21.08
-0.8% | 3/10/2025 | Initiated by | Guggenheim | Analyst Michael Schmidt | Buy | $45.00 | Medium | View details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 3/10/2025 |
NMRA Neumora Therapeutics | $0.77
-1.1% | 3/7/2025 | Downgraded by | Guggenheim | Analyst Yatin Suneja | Buy -> Neutral | | High | View details for Guggenheim rating of Neumora Therapeutics (NASDAQ:NMRA) on 3/7/2025 |
ARRY Array Technologies | $5.15
+7.7% | 3/7/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Neutral -> Buy | $10.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 3/7/2025 |
NOVA Sunnova Energy International | $0.20
+4.0% | 3/5/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Hold -> Strong-Buy | | Medium | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 3/5/2025 |
ANIP ANI Pharmaceuticals | $70.69
-0.2% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $84.00 -> $86.00 | Medium | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/5/2025 |
AZO AutoZone | $3,733.25
-0.8% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $3,750.00 -> $3,850.00 | Medium | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 3/5/2025 |
DUK Duke Energy | $121.32
-0.6% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $132.00 -> $135.00 | Low | View details for Guggenheim rating of Duke Energy (NYSE:DUK) on 3/5/2025 |
FUN Cedar Fair | $34.96
+1.6% | 3/5/2025 | Target Lowered by | Guggenheim | Analyst C. Baker | Buy -> Buy | $55.00 -> $50.00 | Low | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 3/5/2025 |
ORCL Oracle | $145.50
+3.4% | 3/5/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $220.00 -> $220.00 | Medium | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 3/5/2025 |
CRWD CrowdStrike | $431.88
+0.7% | 3/5/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2025 |
BBY Best Buy | $67.09
+0.6% | 3/5/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $105.00 -> $90.00 | Medium | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 3/5/2025 |
GEV GE Vernova | $382.27
+3.1% | 3/5/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Neutral -> Buy | $380.00 | Medium | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 3/5/2025 |
SION Sionna Therapeutics | $12.90
+7.2% | 3/4/2025 | Initiated by | Guggenheim | Analyst Y. Suneja | Buy | $45.00 | Low | View details for Guggenheim rating of Sionna Therapeutics (NASDAQ:SION) on 3/4/2025 |
FE FirstEnergy | $42.77
-0.3% | 2/28/2025 | Target Lowered by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $52.00 -> $45.00 | Medium | View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 2/28/2025 |
ESTC Elastic | $86.05
-0.2% | 2/28/2025 | Target Raised by | Guggenheim | Analyst H. Ma | Buy -> Buy | $130.00 -> $136.00 | High | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 2/28/2025 |
NXST Nexstar Media Group | $144.68
-3.3% | 2/28/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $210.00 -> $220.00 | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 2/28/2025 |
LTH Life Time Group | $30.98
+1.0% | 2/28/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $32.00 -> $36.00 | High | View details for Guggenheim rating of Life Time Group (NYSE:LTH) on 2/28/2025 |
Massive new energy source found in Utah (Ad) NEW THIS WEEK: Huge Energy Discovery In Utah
The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested. Find out what billionaires already know about this new energy source |
CRM Salesforce | $269.17
+0.2% | 2/27/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Sell -> Sell | $247.00 -> $247.00 | High | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 2/27/2025 |
PARA Paramount Global | $11.65
-0.8% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 2/27/2025 |
SNOW Snowflake | $165.52
+3.8% | 2/27/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Snowflake (NYSE:SNOW) on 2/27/2025 |
JACK Jack in the Box | $26.11
+0.3% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $55.00 -> $55.00 | Medium | View details for Guggenheim rating of Jack in the Box (NASDAQ:JACK) on 2/27/2025 |
BEAM Beam Therapeutics | $19.83
-0.5% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $78.00 -> $78.00 | High | View details for Guggenheim rating of Beam Therapeutics (NASDAQ:BEAM) on 2/27/2025 |
PLNT Planet Fitness | $94.85
+0.3% | 2/27/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $105.00 -> $105.00 | Low | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 2/27/2025 |
FSLR First Solar | $126.57
+0.6% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $335.00 -> $304.00 | High | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 2/27/2025 |
ITRI Itron | $108.05
-2.9% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $135.00 -> $133.00 | Low | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 2/27/2025 |
TKO TKO Group | $163.41
+0.3% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $170.00 -> $175.00 | High | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 2/27/2025 |
TXRH Texas Roadhouse | $166.74
+0.5% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $205.00 -> $200.00 | Low | View details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 2/27/2025 |
VERA Vera Therapeutics | $23.75
+1.6% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $59.00 -> $61.00 | Low | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 2/27/2025 |
NRG NRG Energy | $114.18
+4.2% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $134.00 -> $145.00 | High | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 2/27/2025 |
PRKS United Parks & Resorts | $44.91
+2.9% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $70.00 -> $72.00 | High | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 2/27/2025 |
BASE Couchbase | $17.84
+1.1% | 2/26/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $30.00 -> $26.00 | High | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 2/26/2025 |
SRE Sempra | $74.72
+0.6% | 2/26/2025 | Target Lowered by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $95.00 -> $87.00 | Low | View details for Guggenheim rating of Sempra (NYSE:SRE) on 2/26/2025 |
HD Home Depot | $358.19
-0.6% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $450.00 -> $450.00 | Medium | View details for Guggenheim rating of Home Depot (NYSE:HD) on 2/26/2025 |
WDAY Workday | $246.61
+0.7% | 2/26/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 2/26/2025 |
PCVX Vaxcyte | $35.24
-1.7% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $160.00 -> $160.00 | High | View details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 2/26/2025 |
PEG Public Service Enterprise Group | $78.61
-1.7% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $98.00 -> $98.00 | Medium | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 2/26/2025 |
RBRK Rubrik | $71.18
+0.9% | 2/26/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $76.00 -> $76.00 | Low | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 2/26/2025 |
ORIC ORIC Pharmaceuticals | $5.57
-2.5% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/26/2025 |
PNW Pinnacle West Capital | $93.45
-1.8% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $100.00 -> $100.00 | Medium | View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 2/26/2025 |
PMN ProMIS Neurosciences | $0.65
+4.9% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | | High | View details for Guggenheim rating of ProMIS Neurosciences (NASDAQ:PMN) on 2/26/2025 |
SRAD Sportradar Group | $23.47
+1.6% | 2/26/2025 | Initiated by | Guggenheim | Analyst Curry Baker | Buy | $27.00 | Low | View details for Guggenheim rating of Sportradar Group (NASDAQ:SRAD) on 2/26/2025 |
MAZE Maze Therapeutics | $10.59
+14.5% | 2/25/2025 | Initiated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy | $19.00 | High | View details for Guggenheim rating of Maze Therapeutics (NASDAQ:MAZE) on 2/25/2025 |
TEM Tempus AI | $51.85
+0.3% | 2/25/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Low | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 2/25/2025 |
VCYT Veracyte | $29.71
-2.6% | 2/25/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $45.00 -> $45.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 2/25/2025 |
CYBR CyberArk Software | $352.10
0.0% | 2/25/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $455.00 -> $455.00 | High | View details for Guggenheim rating of CyberArk Software (NASDAQ:CYBR) on 2/25/2025 |
TSLA Tesla | $280.52
-0.6% | 2/25/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | | High | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 2/25/2025 |
INSM Insmed | $72.64
+0.9% | 2/25/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $101.00 -> $101.00 | Medium | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/25/2025 |
MTSR Metsera | $23.36
-3.1% | 2/25/2025 | Initiated by | Guggenheim | Analyst Seamus Fernandez | Buy | $56.00 | High | View details for Guggenheim rating of Metsera (NASDAQ:MTSR) on 2/25/2025 |
LNT Alliant Energy | $60.55
-0.8% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $57.00 -> $57.00 | Medium | View details for Guggenheim rating of Alliant Energy (NASDAQ:LNT) on 2/24/2025 |
GH Guardant Health | $48.87
+3.5% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $56.00 -> $56.00 | Medium | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 2/24/2025 |
SPOT Spotify Technology | $601.80
-2.0% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $675.00 -> $675.00 | Low | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 2/24/2025 |
MLYS Mineralys Therapeutics | $14.96
+5.3% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Low | View details for Guggenheim rating of Mineralys Therapeutics (NASDAQ:MLYS) on 2/24/2025 |
WMT Walmart | $97.44
+0.2% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $100.00 -> $100.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 2/24/2025 |
BRKR Bruker | $39.35
-1.8% | 2/24/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Low | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 2/24/2025 |
TARS Tarsus Pharmaceuticals | $50.30
-3.1% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $75.00 -> $78.00 | High | View details for Guggenheim rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/24/2025 |
ARQT Arcutis Biotherapeutics | $14.65
-1.7% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 2/24/2025 |
RIVN Rivian Automotive | $13.76
+0.7% | 2/24/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $18.00 -> $16.00 | Low | View details for Guggenheim rating of Rivian Automotive (NASDAQ:RIVN) on 2/24/2025 |
WING Wingstop | $259.67
-1.6% | 2/24/2025 | Upgraded by | Guggenheim | Analyst Gregory Francfort | Neutral -> Buy | $280.00 | Low | View details for Guggenheim rating of Wingstop (NASDAQ:WING) on 2/24/2025 |
CMPX Compass Therapeutics | $1.82
-2.2% | 2/24/2025 | Initiated by | Guggenheim | Analyst Michael Schmidt | Buy | $12.00 | Medium | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 2/24/2025 |
CHWY Chewy | $36.37
-3.0% | 2/4/2025 | Target Set by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $42.00 | Medium | View details for Guggenheim rating of Chewy (NYSE:CHWY) on 2/4/2025 |
ZVRA Zevra Therapeutics | $7.64
+4.2% | 2/4/2025 | Target Set by | Guggenheim | Analyst E. Hickman | Buy -> Buy | $21.00 | High | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 2/4/2025 |
VG Venture Global | $8.72
+3.9% | 2/18/2025 | Initiated by | Guggenheim | Analyst S. Pourreza | Buy | $27.00 | High | View details for Guggenheim rating of Venture Global (NYSE:VG) on 2/18/2025 |
PCG PG&E | $16.67
+0.9% | 2/18/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Low | View details for Guggenheim rating of PG&E (NYSE:PCG) on 2/18/2025 |
NKE NIKE | $56.80
+0.7% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $110.00 -> $110.00 | Low | View details for Guggenheim rating of NIKE (NYSE:NKE) on 2/12/2025 |
CPRI Capri | $15.07
+0.2% | 2/12/2025 | Reiterated by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for Guggenheim rating of Capri (NYSE:CPRI) on 2/12/2025 |
MRUS Merus | $45.45
-0.1% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 2/12/2025 |
UTL Unitil | $58.95
+0.5% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $55.00 -> $55.00 | High | View details for Guggenheim rating of Unitil (NYSE:UTL) on 2/12/2025 |
AN AutoNation | $174.97
+0.5% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | | Low | View details for Guggenheim rating of AutoNation (NYSE:AN) on 2/12/2025 |
MRK Merck & Co., Inc. | $83.30
-2.2% | 2/12/2025 | Target Lowered by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $122.00 -> $115.00 | Low | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 2/12/2025 |
TDC Teradata | $21.64
+0.6% | 2/12/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $42.00 -> $37.00 | High | View details for Guggenheim rating of Teradata (NYSE:TDC) on 2/12/2025 |
CFLT Confluent | $19.44
-18.4% | 2/12/2025 | Target Raised by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $35.00 -> $38.00 | High | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 2/12/2025 |
OS Onestream | $22.06
+3.1% | 2/12/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $35.00 -> $35.00 | High | View details for Guggenheim rating of Onestream (NASDAQ:OS) on 2/12/2025 |
ARVN Arvinas | $7.23
-24.8% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $57.00 -> $57.00 | High | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 2/12/2025 |
EXEL Exelixis | $38.89
-0.7% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $42.00 -> $42.00 | High | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 2/12/2025 |
FLNC Fluence Energy | $4.28
+4.6% | 2/11/2025 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Sell | $26.00 -> $6.00 | High | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 2/11/2025 |
SNAP Snap | $7.83
-1.7% | 2/11/2025 | Downgraded by | Guggenheim | Analyst M. Morris | Buy -> Neutral | | Medium | View details for Guggenheim rating of Snap (NYSE:SNAP) on 2/11/2025 |
RZLT Rezolute | $3.96
+5.3% | 2/10/2025 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | | Low | View details for Guggenheim rating of Rezolute (NASDAQ:RZLT) on 2/10/2025 |
